Skip to main content
Clinical Trials/JPRN-UMIN000026993
JPRN-UMIN000026993
Completed
未知

PRediction of Opioid-induced respiratory Depression In patients monitored by capnoGraphY (PRODIGY) - PRODIGY

Covidien Japan Inc.0 sites1,650 target enrollmentApril 21, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Patients monitored by capnoGraphY
Sponsor
Covidien Japan Inc.
Enrollment
1650
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 21, 2017
End Date
May 6, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Expected length of stay \=\<24 hours. 2\.Patient is receiving intrathecal opioids. 3\.Post\-surgical patients with American Society of Anesthesiologists physical status (ASA PS) V or higher. 4\.Patients with the status of Do Not Resuscitate (DNR), hospice, or receiving end of life therapy. 5\.Ventilated or intubated patients. 6\.Patient is unwilling or unable to comply fully with study procedures (including non\-toleration of the capnography cannula) due to any disease condition which can raise doubt about compliance and influencing the study outcome. 7\.Patient is a member of a vulnerable population, includinglegal incapacity or evidence that a subject cannot understand the purpose and risks of the study, regardless of authorized representative support. 8\.Patient is participating in another potentially confounding drug or device clinical study.

Outcomes

Primary Outcomes

Not specified

Similar Trials